Fermenta Biotech Limited (BOM:506414)
India · Delayed Price · Currency is INR 342.30
-16.90 (-4.70%)
At close: Mar 27, 2026
Fermenta Biotech Market Cap
Fermenta Biotech has a market cap or net worth of 10.57 billion as of March 27, 2026. Its market cap has increased by 44.98% in one year.
Market Cap
10.57B
Enterprise Value
11.12B
Revenue
5.44B
Ranking
n/a
PE Ratio
12.16
Stock Price
342.30
Market Cap Chart
Since July 31, 1998, Fermenta Biotech's market cap has increased from 335.80M to 10.57B, an increase of 3,048.20%. That is a compound annual growth rate of 13.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 10.57B | 3.22% |
| Dec 31, 2025 | 10.24B | -4.38% |
| Dec 31, 2024 | 10.71B | 129.56% |
| Dec 29, 2023 | 4.67B | -6.88% |
| Dec 30, 2022 | 5.01B | -40.13% |
| Dec 31, 2021 | 8.37B | -8.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shukra Pharmaceuticals | 15.60B |
| Amrutanjan Health Care | 15.33B |
| Kwality Pharmaceuticals | 15.19B |
| Lincoln Pharmaceuticals | 11.87B |
| Venus Remedies | 11.56B |
| TTK Healthcare | 11.05B |
| Syncom Formulations (India) | 10.70B |
| Wanbury | 8.44B |